Asia · Markets & Finance · Business Standard

Emcure Pharma up over 3% as board approves merger of two subsidiaries

Published by Business Standard · India 3 h ago

Emcure Pharmaceuticals will merge its wholly owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, with itself under the proposed scheme.

Read the full article on Business Standard Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.business-standard.com)

Also worth reading

Tech in Asia

A16z seeks South Korean chip, robotics partnerships

Mint

Q2 results 2026: Can corporate earnings halt Sensex, Nifty sell-off? Experts decode

The Economic Times

GCCs drive 41% of India's office leasing

The Straits Times Business

Starbucks Korea regains coffee chain lead five months after ‘Tank Day’ controversy

SCMP Business

Former HSBC executive launches wealth platform powered by team of AI agents

The Business Times